Altamira Therapeutics Other Current Assets

Altamira Therapeutics (CYTO) currently reports a other current assets of $190K as of December 2024. That compares with $610K in the prior-year period — down 68.5% year over year. Use the charts on this page to explore Altamira Therapeutics's other current assets history and peer comparisons.

Altamira Therapeutics's other current assets decreased from $610K to $190K — a 68.5% year-over-year decrease (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Altamira Therapeutics reported $190K in other current assets as of December 2024. That compares with $610K in the prior-year period — down 68.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $190K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Altamira Therapeutics, and consider following CYTO for alerts when major investors trade the stock.

Altamira Therapeutics is classified in the Healthcare sector. On other current assets, it currently shows $190K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CYTO with unrelated industries.